Navigation Links
SGX Pharmaceuticals Announces First Quarter Financial Results and Gives Pipeline Update
Date:5/13/2008

e hereof.

SGX PHARMACEUTICALS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

Three Months Ended

March 31,

2008 2007

Revenue:

Collaborations and

commercial agreements $15,001 $5,647

Grants 1,971 5,321

Total revenue 16,972 10,968

Operating expenses:

Research and development 11,349 10,018

General and administrative 2,121 2,233

Total operating expenses 13,470 12,251

Income (loss) from operations 3,502 (1,283)

Interest income and expense, net 219 185

Net income (loss) $3,721 $(1,098)

Net income (loss) per common share:

Basic $0.18 $(0.07)

Diluted $0.18 $(0.07)

Shares used to compute

basic and diluted net

income (loss) per common share:

Basic 20,530 15,228

Diluted 21,089 15,228

Three Months Ended Three Months Ended

March 31, 2008 (1) March 31, 2007 (1)

Stock- Stock-

based Reported based Reported

compensation GAAP compensation GAAP

non-GAAP expense results non-GAAP expense results

Net income (loss) $4,347 $(626) $3,721 $(109) $(989) $(1,098)

Basic net income

(loss) per common

share:
'/>"/>

SOURCE SGX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 2015 CIRTEC Medical Systems, ... services for complex Class III implantable devices ... to develop a new 35,000 sq. ft. advanced ... has a long history of working with world’s ... breakthrough neurostimulation, heart assistance, drug delivery and smart ...
(Date:4/28/2015)... The Pistoia Alliance, a global, not-for-profit ... lower barriers to innovation in R&D, has announced the ... The Ontologies Mapping project has been set up to ... management in life sciences R&D. The project will see ... tools and services to enable the universal application of ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 According to ... than 450,000 patients receive medical treatment from burn injuries ... of burn injury, extensive formation of scars with subsequent ... burn patients for which there is no adequate treatment. ... prevent normal movement and can cause permanent deformity. ...
(Date:4/28/2015)... April 28, 2015 Reproductive endocrinologist Dr. ... in 7 couples battling infertility in this country, testified on ... Texas as the first state in the nation to consider ... embryos to couples who desire to receive them. , Infertility ... fact that infertility is one of the few medical diseases ...
Breaking Biology Technology:CIRTEC Medical Systems Expands Capacity with New Advanced Manufacturing Facility 2Pistoia Alliance Announces Start of Ontologies Mapping Project 2Synedgen Burn Treatment Results Presented at Premier Wound Conference 2Synedgen Burn Treatment Results Presented at Premier Wound Conference 3Texas Fertility Center Supports a Groundbreaking HB1145 that Facilitates Embryo Donation in Texas 2Texas Fertility Center Supports a Groundbreaking HB1145 that Facilitates Embryo Donation in Texas 3
... (Amex: CPD ) posted net sales for the ... $108.3 million, as compared to $35.4,million for the corresponding ... over the first quarter of Fiscal 2008. Pre-tax income ... 2009 as compared to a,pre-tax income of $9.6 million ...
... Inc. (Nasdaq:,INSM), a developer of follow-on biologics and ... call on Friday, August 8th at 8:30,AM ET, ... 2008. Insmed intends,to issue its quarterly financial results ... To participate in the live conference call, ...
... 24 /PRNewswire-FirstCall/ - MIGENIX Inc.,(TSX: MGI; OTC: MGIFF), ... that the directors of MIGENIX Inc. have called ... held at 2:00 p.m. (Vancouver,time) on October 31, ... Vancouver,British Columbia. Further details with respect to the ...
Cached Biology Technology:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7Insmed to Host Second Quarter 2008 Conference Call 2
(Date:4/27/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... the first week of May, 2015 and will be ... Gino Pereira , Chief Executive ... company as Wocket® enters the consumer market. We would ...
(Date:4/17/2015)... Canada , April 17, 2015 ... growing security concerns, and technological advancement to drive ... until 2020   According ... Saudi Arabia Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric systems ... is projected to register growth at CAGR of ...
(Date:4/10/2015)... DUBLIN , April 10, 2015 ... the addition of the "Security Competitive Profiles - ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , NEC will continue to ... solutions to the market, with a company focus on ... solution anticipated. Winning opportunities in the ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NEC Security Competitive Profile 2015 2
... (ret) Dale Meyerrose,Chief Information Officer, Office of the ... and Greg Garcia, Assistant Secretary for,Cybersecurity and Telecommunications, ... the Information Assurance community as the keynote,speaker. ... in the federal IA community has collaborated to,create ...
... this - IV (intravenous) lines in a sorghum ... one way that scientists at,the Texas Agricultural Experiment ... biofuel revolution. In Beaumont, Dr. Lee Tarpley, ... professor of crop physiology, have focused,their research on ...
... PITTSBURGH, September 12, 2007 A double amputee whose ... led to the development of new prosthetic innovations that ... the 13th annual Heinz Award for Technology, the Economy ... the world. Dr. Hugh Herr, 43, ...
Cached Biology News:Herr receives Heinz Award for Technology, the Economy and Employment 2Herr receives Heinz Award for Technology, the Economy and Employment 3Herr receives Heinz Award for Technology, the Economy and Employment 4
...
... The Polymerase gene from Thermus ... expressed in E. coli, then highly ... It is used in the amplification ... PCR. The quality of the Taq ...
Rabbit polyclonal to hnRNP-U...
... is a nonspecific endonuclease that degrades double-and ... hydrolyzing phosphodiester linkages, producing mono and oligonucleotides ... Ambion's RNase-free DNase I is of the ... degrade DNA in the presence of RNA ...
Biology Products: